Clinical Trial Resource Center


Therapeutic Areas: Oncology | Dermatology | Family Medicine

Squamous Cell Carcinoma Clinical Trials


A listing of Squamous Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Tuscaloosa : DCH Cancer Center

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Arizona

Casa Grande : Cancer Treatment Services - AZ

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Scottsdale : Southwest Oncology Centers

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Scottsdale : Mayo Clinic Arizona (Site 229)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tucson : Arizona Clinical Research Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Arkansas

Hot Springs : Genesis Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Duarte : City of Hope, Site #009

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : Moores Cancer Center University of California, San Diego, Site #099

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : Moores UC San Diego Cancer Center

A clinical trial to evaluate treatments using GL-ONC1 for patients with Cancer of Head and Neck

La Jolla : Call for Information (Investigational Site 0011) Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Los Angeles : UCLA Hematology-Oncology Clinic

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles : Cedars-Sinai Medical Center

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Oxnard : Ventura County Hematology-Oncology Specialists Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pleasant Hill : Diablo Valley Oncology and Hematology Medical Group

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

San Diego : Kaiser Permanente, Site #208

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

San Jose : Global Cancer Research Institute Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Colorado

Aurora : University of Colorado Cancer Center, Site #015

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aurora : University of Colorado Cancer Center

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Denver : Rocky Mountain Cancer Centers Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Connecticut

New Haven : Yale Cancer Center (Site 033)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

District of Columbia

Washington : Georgetown Lombardi Comprehensive Cancer Center

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Boca Raton : Lynn Cancer Institute/Boca Raton Regional Hospital Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Jacksonville : Baptist Cancer Institute Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Worth : Cancer Center of South Florida, Site #204

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

New Orleans : Ochsner Health System/The Gayle and Tom Benson Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ocala : Ocala Oncology Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Orlando : Florida Hospital Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Tampa : H. Lee Moffitt Cancer Center (Site 017)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Tampa : Lee Moffitt Cancer Center and Research Institute

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Georgia

Athens : Call for Information (Investigational Site 0029) Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Atlanta : Winship Cancer Institute of Emory University, Site #058

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Illinois

Chicago : The University of Chicago Medical Center

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

Chicago : University of Chicago (Site 001)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chicago : The University of Chicago

A clinical trial to evaluate treatments using MGA271 for patients

Evanston : Northshore University Health System Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Niles : Oncology Specialists, S.C. Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Indiana

Indianapolis : Saint Francis Medical Group Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kansas

Wichita : Cancer Center of Kansas Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kentucky

Paducah : Western Kentucky Hematology and Oncology Group Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : West Jefferson Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Maryland

Baltimore : Medstar Research Institute Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Baltimore : University of Maryland Greenebaum Cancer Center

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Massachusetts

Boston : Massachusetts General Hospital Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Dana Farber Cancer Institute

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Boston : Dana-Farber Cancer Institute / Harvard University

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Boston : Tufts Medical Center

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Framingham : Metrowest Medical Center

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Worcester : Reliant Medical Group Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Michigan

Detroit : Henry Ford Health System Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Detroit : Karmanos Cancer Institute

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Detroit : Karmanos Cancer Institute

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Minnesota

Rochester : Mayo Clinic (Site 044)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Missouri

St. Louis : Call for Information (Investigational Site 0001) Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

St. Louis : Washington University School of Medicine / Washington University in St. Louis

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Nebraska

Omaha : Nebraska Methodist Hospital Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New Jersey

Cherry Hill : Regional Cancer Care Associates/Cherry Hill Division, LLC. Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

East Brunswick : Regional Cancer Care Associates Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Hackensack : Hackensack University Medical Center

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Livingston : Saint Barnabas Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Somerville : Regional Cancer Care Associates/ Somerset Division Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Sparta : Regional Cancer Care Associates/Sparta Division Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New York

Bronx : Montefiore Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Johnson City : Broome Oncology, LLC Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Success : Clinical Research Alliance Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New York : Icahn School of Medicine at Mount Sinai

A clinical research study of ADXS11-001 (ADXS-HPV) for the treatment of Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck or Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

New York : Herbert Irving Comprehensive Cancer Center / Columbia University

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

New York : Icahn School of Medicine at Mount Sinai

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Syracuse : State University of New York Upstate Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

North Carolina

Chapel Hill : Lineberger Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Chapel Hill : UNC Health Care; N.C. Cancer Hospital Infusion/Inpatient Pharmacy (CHIP) (Site 032)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chapel Hill : The University of North Carolina at Chapel Hill

A Phase 2 clinical study for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Charlotte : Carolinas Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Charlotte : Novant Health Presbyterian Medical Center

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Novant Health Presbyterian Medical Center, Site #205

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Levine Cancer Institute

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Winston-Salem : Novant Health Oncology Specialists/Forsyth Memorial Hospital Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ohio

Canton : Gabrail Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Canton : Gabrail Cancer Center

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Oregon

Corvallis : Samaritan Hematology & Oncology Consultants Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Portland : Oregon Health and Science University Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pennsylvania

Hershey : Penn State/Milton S Hershey Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Philadelphia : Thomas Jefferson University Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Philadelphia : University of Pennsylvania

A clinical trial seeking patients for a research study for the treatment of Aerodigestive Malignancies (e.g Squamous Cell Carcinoma)

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Pittsburgh : Allegheny Singer Research Institute Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Tennessee

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Vanderbilt-Ingram Cancer Center / Vanderbilt University

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Nashville : Sarah Cannon Research Institute - Tennessee Oncology

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Texas

Amarillo : Texas Oncology, P.A. Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas : Baylor University Medical Center at Dallas Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas : Mary Crowley Cancer Research Center / Texas Oncology

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Galveston : University of Texas Medical Branch Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Houston : UT MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Paranasal Sinus Neoplasms or Squamous Cell Carcinoma

Houston : UT MD Anderson Cancer Center (Site 005)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Longview : Texas Oncology, P.A./Longview Cancer Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Washington

Seattle : Virginia Mason Medical Center Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Seattle : Swedish Cancer Institute (Site 211)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seattle : University of Washington

A Phase 2 clinical study for patients with Advanced Squamous Cell Carcinoma (SCC) of Head and Neck, Lung, or Esophagus

Vancouver : Northwest Cancer Specialists, PC Updated

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Australia

Camperdown : Chris O'Brien Lifehouse

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Fitzroy : St Vincent's Hospital Melbourne (Site997)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Frankston : Peninsula & South Eastern Haematology Group (Site 994)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kogarah : The St George Hospital, Cancer Care Center (Site 403)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

St. Leonards : Royal North Shore Hospital

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Woolloongabba : Priness Alexandra Hospital, Cancer Services (Site 942)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Woolloongabba : Veracity Clinical Research Pty Ltd

Patients are needed to participate in a clinical research study of BLZ-100 to evaluate Skin Neoplasms

Austria

Salzburg : St.-Johanns-Spital, Universitatsklinik fur Pneumologie/Lungenheilkunde (Site 627)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Wien : SMZ Baumgartner Hohe Otto Wagner Spital, Onkologische Ambulanz+Tagesklinik (Site 612)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Belgium

Brussels : MSD Belgium BVBA/SPRL Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Gent : University Hospital Gent

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Roeselare : H.-Hartziekenhuis Roeselare-Menen vzw (Site 617)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Canada

Kirkland : Merck Canada Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Ottawa : The Ottawa Hospital Cancer Centre (Site 131)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Toronto : Princess Margaret Cancer Center

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Toronto : Princess Margaret Hospital

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

China

Shanghai : Shanghai Chest hospital

A clinical trial seeking patients for a research study for the treatment of Squamous Cell Carcinoma

Denmark

Copenhagen : Rigshospitalet

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

DK 2730 Herlev : Herlev Hospital (Site 614)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Odense C : Odense University Hospital (Site 615)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

France

Nancy : Centre Alexis Vautrin (CAV)-Nancy Université Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Paris : MSD France Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Germany

Berlin : Evangelische Lungenklinik Berlin (Site 588)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Halle : Krankenhaus Martha Marie Halle (Site 572)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Heidelberg : Thoraxklinik-Heidelberg gGmbH, Innere Medizin - Onkologie (Site 586)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hemer : Lungenklinik Hemer, Zentrum fur Pneumologie und Thoraxchirurgie (Site 620)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kassel : Klinikum Kassel GmbH, Klinik fur Onkologie und Hamatologie (Site 573)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Lübeck : Universitätsklinikum Schleswig-Holstein Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Munchen : LMU - Klinikum der Universitat Munchen, Campus Innenstadt, Medizinische Klinik V, Pneumologie (Site 609)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

München : Ludwig Maximilian University Munich Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Hong Kong

Hong Kong : Queen Mary Hospital, Department of Clinical Oncology (Site 986)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hong Kong : Queen Mary Hospital, Division of Respiratory and Critical Care Medicine (Site 973)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kowloon : Queen Elizabeth Hospital, Department of Clinical Oncology (Site 987)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Ireland

Dublin : MSD Ireland (Human Health) Ltd. Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Italy

Aviano : S.O.C. Oncologia Medica A, Centro di Riferimento Oncologico, I.R.C.C.S., Istituto Nazionale Tumori (Site 624)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Brindisi : U.O.C. Oncologia Medica, Ospedale A. Perrino, Presidio Ospedaliero Di Summa - Perrino, Azienda Sanitaria Locale di Brindisi (Site 629)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Meldola (FC) : U.O. Oncologia Medica, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)_IRCCS (Site 575)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Divisione Oncologia Toracica, Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico (Site608)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Dipartimento di Oncologia Medica Ospedale San Raffaele, Istituto di Ricovero e Cura a Carattere Scientifico (Site 578)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Parma : Struttura Complessa Oncologia Medica Azienda Ospedaliero-Universitaria di Parma (Site 607)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rome : MSD Italia S.r.l. Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Korea, Republic of

Goyang-si : National Cancer Center (Site 916)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : The Catholic University of Korea Seoul St. Mary's Hospital (Site 938)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Severance Hospital, Yonsei University Health System (Site 913)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Asan Medical Center (Site 917)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Seoul National University Hospital (Site 915)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : MSD Korea LTD Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Lithuania

Vilnius : Institute of Oncology, Vilnius University Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Vilnius : UAB "Merck Sharp & Dohme" Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Netherlands

Amsterdam : The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Amsterdam : The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (Site 579)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Amsterdam : VU Medical Center (Site 948)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Groningen : University Medical Center Groningen (Site 581)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Masstricht : Maastricht UMC+ (Site 580)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Portugal

Paco D'arcos : Merck Sharp & Dohme Lda. Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Puerto Rico

Ponce : Call for Information (Investigational Site 0096) Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

San Juan : Call for Information (Investigational Site 0101) Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Russian Federation

Moscow : Merck Sharp & Dohme IDEA, Inc. Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Singapore

Singapore : National Cancer Centre Singapore, Depart of Medical Oncology (Site 989)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Singapore : OncoCare Cancer Centre (Site 988)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Spain

A Coruna : Hospital Teresa Herrera (Site 554)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Alicante : Hospital General Universitario de Alicante (Site 591)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitari de la Vall d'Hebron Servicio de Oncologia Medica (Site 503)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitario Quiron Dexeus, Servicio de Oncologia Medica (Site 590)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Madrid : Hospital Universitario La Paz (Site 582)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Madrid : Merck Sharp and Dohme de Espana S.A. Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Palma de Mallorca : Hospital Son Llatzer (Site 625)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Valencia : Hospital Clinico Universitario de Valencia (Site 589)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Sweden

Goteborg : Sahlgrenska Universitetssjukhuset (Site 758)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Stockholm : Karolinska Universitetssjukhuset

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Switzerland

Bern : Inselspital - Universitatsspital Bern

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Lucerne 6 : MSD International GmbH Updated

A clinical trial to evaluate treatments using pembrolizumab, methotrexate, docetaxel and cetuximab for patients with Head and Neck Squamous Cell Cancer

Winterthur : Kantonsspital Winterthur

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

United Kingdom

London : University College London Hospital Updated

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Manchester : The Christie NHS Foundation Trust (Site 725)

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Stay Informed
Sign up for e-newsletters, major
events and research alerts!

3520 Lake Ave., Ste 202, Wilmette, IL 60091 | Office: 847.424.0600 | Fax: 847.424.0606 | Contact Us